Valganciclovir

Valganciclovir

Another Name
LuciValgan、Valganciclovir、缬更昔洛韦、万赛维
Indications
Valcyte treatment for cytomegalovirus infection.
Reg No
06 L 1104/24
Inspection No
1092-24
dosage form:Pills
Specs:450mg * 60 Pills
Indate:2 years
Date：2024-9-1 Views：1178
Drug Info

COMPOSITION:

Each film-coated tablet contains Valganciclovir HCl 496.3 mg equivalent to Valganciclovir………450mg.

INDICATION:

LuciValgan is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for:

Adult Patients:

• Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS).

• Prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk.

Pediatric Patients:

• Prevention of CMV disease in kidney and heart transplant patients at high risk.

DOSAGE AND USE:

See full prescribing information for LuciValgan.

STORAGE:

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administer LuciValgan during Pregnancy and Lactation.

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/valganciclovir/

Related News